The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
The Positive and Negative Syndrome Scale (PANSS): Rationale and Standardisation
Abstract
Over 75 years ago, Bleuler (1911) confronted psychiatry with the question of ‘schizophrenia’ or ‘schizophrenias'. Today we recognise the heterogeneity of the condition, but we are still groping at efforts to clarify the different subtypes or subprocesses. Over the decades there have been various attempts to subclassify schizophrenia and tease apart the syndromes, none of which has been entirely successful. More recently, as a result of the work by Crow (1980) in England and Strauss et al (1974) in the USA, it has been proposed that two distinct syndromes can be discerned from the phenomenological profiles. The positive syndrome consists of productive features superadded to the mental status, such as delusions, hallucinations, and disorganised thinking. The negative syndrome represents absence of normal functions, such as deficits in the cognitive, affective, and social realms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Participants’ mental health status was measured using the Positive And Negative Syndrome Scale (PANSS; Kay et al. 1989), the Global Assessment of Functioning (GAF; American Psychiatric Association, 2002) and the Montgomery–Åsberg Depression Rating Scale (MADRS; Montgomery & Åsberg, 1979).”
From Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial (2015) · cites this paper as Kay et al. 1989
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
(1976) · Medical Entomology and Zoology · Cited by 8,899
Dementia Praecox or the Group of Schizophrenias
(1951) · Journal of the American Medical Association · doi:10.1001/jama.1951.02920270079043 · Cited by 4,407
Negative Symptoms in Schizophrenia: Definition and Reliability
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247
Reliability and validity of the positive and negative syndrome scale for schizophrenics
Kay, S. R., Opler, L. A., & Lindenmayer, J.-P. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90038-8 · Cited by 1,007
The Prediction of Outcome in Schizophrenia
Strauss, J. S. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760130021003 · Cited by 645
Part III. Speculations on the Processes That Underlie Schizophrenic Symptoms and Signs
Strauss, J., Carpenter, W. T., & Bartko, J. J. (1974) · Schizophrenia Bulletin · doi:10.1093/schbul/1.11.61 · Cited by 574
Positive and Negative Schizophrenic Symptoms and the Role of Dopamine
Crow, T. J. (1980) · The British Journal of Psychiatry · doi:10.1192/s0007125000071919 · Cited by 563
Treatment of Negative Symptoms
Carpenter, W. T., Heinrichs, D. W., & Alphs, L. D. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.440 · Cited by 508
Research works printed but not linked: 2
- Opler, 1987, Positive and Negative Symptoms in Psychosis: Description, Research, and Future Directions in Positive and Negative Symptoms in Psychosis: Description, Research, and Future Directions, 124
- Kay, 1981, Arousal and schizophrenia: Toward a dual-process model and framework for research, JSAS Catalog of Selected Documents in Psychology, 11
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Wywiad ustrukturyzowany w ocenie zaburzeń psychotycznych na przykładzie kwestionariusza sans i saps
Cyrkot, T., Gawęda, Ł., & Szczepanowski, R. (2016) · Cited by 1
Schizophrenia and toxoplasmosis: association with catatonic symptoms
Romanov, D. V., Brazhnikov, A. Y., Andreyuk, D., Zakharova, N. V., Bravve, L. V., Kovaleva, V. A., Abbazova, E. V., Goncharov, D. B., Titova, I. V., Алексеевна, Д. Э., et al. (2020) · Consortium Psychiatricum · doi:10.17650/2712-7672-2020-1-1-22-29 · Cited by 1
“Bleuler’s criteria [11] and a psychometric evaluation of symptoms using the PANSS scale [12, 13].”
BackgroundMethodFateminasab, M. S., Raaii, F., ., A. G., & Pouya, F. S. (2021) · Thrita · doi:10.5812/thrita.113930 · Cited by 1
“The PANSS is a 30-item scale, in which each item is rated on a seven-point Likert scale (ranging from normal to extremely abnormal) with sub-scores for seven positive (P), seven negative (N), and 16 global psychopathological symptoms (19).”
BackgroundA study of emotional intelligence in an Egyptian sample of offspring of patients with schizophrenia
ElSehrawy, T. M. K., Elella, E. A., Hassan, G. A. M., Missiry, M. E., Nabi, S. A., & Soliman, A. (2022) · Middle East Current Psychiatry · doi:10.1186/s43045-022-00216-x · Cited by 1
“The patient is rated from 1 to 7 on 30 different symptoms based on the interview as well as reports of family members or primary care hospital workers [10].”
BackgroundKolla, N. J., Aloysius, R., Gainham, G., & Hawco, C. S. (2024) · JAACAP Open · doi:10.1016/j.jaacop.2024.04.001 · Cited by 1
“As expected, analyses of variance revealed a difference between groups in PANSS scores and olanzapine equivalent antipsychotic usage, but results of t tests between FEP and FEP þ CD groups were non-signi fi cant.”
InfluentialMaturana-Candelas, A., Rodríguez-González, V., Gijón-Ortego, J., Iglesias‐Parro, S., Ibáñez-Molina, A. J., Gómez, C., & Poza, J. (2024) · IEEE International Conference on Metrology for eXtended Reality, Artificial Intelligence and Neural Engineering (MetroXRAINE) · doi:10.1109/metroxraine62247.2024.10795910 · Cited by 1
Francis, A. M., Anderson, T.-J., McKearney, K. J., Schryver, B., Tibbo, P. G., & Fisher, D. J. (2025) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2025.112006 · Cited by 1
Zhang, Q., Sui, A., Su, M., Ju, M., Wei, Y., Tang, X., Xu, L., Cui, H., Tang, Y., Yi, Z., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1642291 · Cited by 1
Management of Schizophrenia in Ayurveda-A Case Report
Adithya, K. S., & Vinod, R. (2022) · International Research Journal of Ayurveda & Yoga · doi:10.47223/irjay.2022.5214
Operators and scales: diagnostic and rating issues in psychiatric PET research
Ågren, H. (1992) · Springer eBooks · doi:10.1007/978-3-7091-9209-2_2 · Cited by 1
Treatment-refractory Schizophrenia: Update on Concepts and Interventions
Littrell, K. H., & Littrell, S. H. (1998) · Journal of the American Psychiatric Nurses Association · doi:10.1016/s1078-3903(98)90027-1 · Cited by 1
Components of Work-related Wellbeing
Booker, L.-J. (2017) · Tuwhera (Auckland University of Technology) · Cited by 1
Developing a New Apathy Measurement Scale
Radaković, R. (2012) · ERA · Cited by 1
Recent Advances in the Understanding of Negative Symptoms in Schizophrenia
Littrell, S. H., & Littrell, K. H. (1997) · Journal of the American Psychiatric Nurses Association · doi:10.1177/107839039700300405 · Cited by 1
Akute Vorübergehende Psychotische Störungen
Marneros, A., & Pillmann, F. (2004) · Springer eBooks · doi:10.1007/978-3-7091-0623-5_5 · Cited by 1
Gainsford, K., Fitzgibbon, B. M., Hill, A. T., Fitzgerald, P. B., Gurvich, C., & Hoy, K. E. (2025) · medRxiv · doi:10.1101/2025.05.09.25327050 · Cited by 1
“The schizophrenia group completed a clinical measure (Positive and Negative Schizophrenia Scale - PANSS; Kay, Opler, & Lindenmayer, 1989) and controls completed the Multidimensional Schizotypy Scale (MSSB-B; Gross, Kwapil, Raulin, Silvia, & Barrantes-Vidal, 2018).”
Moritz, S., Naber, D., Lausen, A. M., Küppers, D., Lambert, M., Karow, A., & Krausz, M. R. (2001) · Springer eBooks · doi:10.1007/978-3-642-59454-0_11 · Cited by 1
Patterns of Clinical Efficacy for Antipsychotic Drugs
Golier, J. A., & Davidson, M. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61007-3_11
Defining the brief, acute and transient psychotic disorders: the polymorphic psychotic core
Marneros, A., & Pillmann, F. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544002.012
Marneros, A., & Pillmann, F. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544002.007
Marneros, A., & Pillmann, F. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544002.010
Epidemiological and biological mechanisms of cannabis as cause of psychosis
Kuepper, R. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120504rk
The Application of Multiplexed Assay Systems for Molecular Diagnostics
Schwarz, E., VanBeveren, N. J. M., Guest, P. C., Izmailov, R., & Bahn, S. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-387718-5.00010-9
Marneros, A., & Pillmann, F. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544002.005
Akute Vorübergehende Psychotische Störungen
Pillmann, F., & Marneros, A. (2004) · Steinkopff eBooks · doi:10.1007/978-3-7985-1957-2_36
Marneros, A., & Pillmann, F. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544002.015
Atypical antipsychotics on depressive symptoms in schizophrenia
Cookson, J. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)80107-3
Ampil, E. R., & Cummings, J. L. (2006) · Progress in Neurotherapeutics and Neuropsychopharmacology · doi:10.1017/s174823210600005x
Einfluß von Olanzapin auf den Schlaf und das deklarative Gedächtnis bei Patienten mit Schizophrenie
Serafin, I. (2009) · MACAU: Open Access Repository of Kiel University (University Library Kiel)
Original article Utility decrements associated with side effects in schizophrenia
Millier, A., Amri, I., Boyer, L., Auquier, P., & Toumi, M. (2014)
Forbes, C. B., & Blanchard, J. J. (2009)
Studies on brief and acute psychoses
Marneros, A., & Pillmann, F. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544002.004
Gender differences in neuropsychological test performance among people with negative schizophrenia
Roberts, K. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Brief polymorphic psychoses as a component of a psychotic continuum
Marneros, A., & Pillmann, F. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544002.014
Marneros, A., & Pillmann, F. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544002.003
Demily, C., & Chouinard, G. (2010)
Die Dauer der unbehandelten Psychose bei erstbehandelten Patienten mit Schizophrenie
Gutachter, E., Krämer, A., Gutachter, Z., & Drießen, M. (2007)
Post-traumatic Stress Disorder and Schizophrenia: A Case Study
Fleming, M. P., & Martin, C. R. (2015) · Springer eBooks · doi:10.1007/978-3-319-08613-2_125-1
The clinical features of the acute episode
Marneros, A., & Pillmann, F. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544002.006
Comorbidity and somatic findings
Marneros, A., & Pillmann, F. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544002.011
Economic evaluation in mental healthcare
Stant, D. A. (2007)
Marneros, A., & Pillmann, F. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544002.001
Dimensionale Struktur der deutschen Version der Brief Psychiatric Rating Scale (BPRS)
Eppendorf, U.-K. (1997)
Trotta, A. (2016) · Research Portal (King's College London)
Impey, D. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-534
Assessment of cognitive functions and cerebral blood flow in patients with schizophrenia
Elserogy, Y., Abdelrahman, A. A., Noaman, M. M., Shehata, G. A., & Khalifa, H. (2017) · Middle East Current Psychiatry · doi:10.1097/01.xme.0000490936.52210.33
Korostil, M., Remington, G. J., & McIntosh, A. R. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00212
“Additionally, persons in the SZ group were more likely to manifest this relationship if they scored higher on cognitive measures and displayed more symptoms of SZ (via the total PANSS score).”
MethodInfluentialJi, S., Li, A., Dong, F., Li, L., Zhou, T.-Y., Wang, C., & Lu, W. (2016) · PubMed
Wang, J., Wydell, T. N., Zhang, L., Quan, W., Tian, J., Jin, L., & Dong, W. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.10.020
Response to the letter from Dr. Kim and colleagues
Kishi, T., Nomura, I., Ikuta, T., & Iwata, N. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.03.040
“…showed a marginal association between the effect size for pooled statin add-on treatment, with respect to the Positive and Negative Syndrome Scale (PANSS) total score (Kay et al., 1989) and PANSS total scores at baseline (total scores: coefficient = 0.0092, 95%CI,− 0.0013 to 0.0196, p=0.0855).”
InfluentialPrise en charge des états dangereux des pathologies mentales graves
Vacheron-Trystram, M.-N., Cornic, F., & Gourévitch, R. (2010) · Elsevier eBooks · doi:10.1016/b978-2-294-71205-0.50005-x
Ampil, E. R., & Cummings, J. L. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse228
Surti, T. S., Vinogradov, S., Bell, M. D., & Wexler, B. E. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.021
Benazzi, F. (1992) · European Psychiatry · doi:10.1017/s0924933800003369
Незнамов, Г. Г., Богданова, И. О., Syunyakov, T., Дорофеева, О. А., Коваленок, Т. В., & Chepeluk, A. A. (2020) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202012002122
Meinert, P., Behr, J., Gauger, U., Krebs, J., Konrad, N., & Opitz‐Welke, A. (2020) · Behavioral Sciences & the Law · doi:10.1002/bsl.2480
Dietrichkeit, M., Grzella, K., Nagel, M., & Moritz, S. (2020) · Verhaltenstherapie · doi:10.1159/000510168
Psychopharmacology of Violence
Volavka, J., & Citrome, L. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316847992.035
Raftery, D., Kelly, P. J., Deane, F. P., Carter, G. L., Dean, O. M., Lubman, D. I., Turner, A., & McKetin, R. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108473
Quantifying the Dynamics of Central Systemic Degeneration in Schizophrenia
Rǎdulescu, A. (2011) · Springer eBooks · doi:10.1007/978-94-007-0837-2_8
Bellack, A. S., & Drapalski, A. L. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.4874960.4802058
Millet, B., Vanelle, J., & Benyaya, J. (2014) · Elsevier eBooks · doi:10.1016/b978-2-294-74176-0.00005-2
Moritz, S., Krieger, E. C., Bohn, F., & Veckenstedt, R. (2017) · Springer eBooks · doi:10.1007/978-3-662-52998-0_2
Eggers, C., & Röpcke, B. (2011) · Springer eBooks · doi:10.1007/978-3-642-19846-5_16
Drug-Induced Non-Motor Symptoms in Parkinson’s Disease
Aquino, C. (2022) · Cambridge University Press eBooks · doi:10.1017/9781009039291.020
Millet, B., Vanelle, J., & Benyaya, J. (2010) · Elsevier eBooks · doi:10.1016/b978-2-294-01922-7.00005-8
MEMORY PROFILES IN SCHIZOPHRENIA: CATEGORIZATION VALIDITY AND STABILITY
Bell, M. D., Johannesen, J., Greig, T. C., & Wexler, B. E. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.286
Historical Perspectives on the History of Measurement in Psychiatry
Aboraya, A. S. (2022) · Advances in mental health and addiction · doi:10.1007/978-3-030-94930-3_1
Moritz, S., Krieger, E. C., Bohn, F., Elmers, J., & Veckenstedt, R. (2022) · Psychotherapie: Manuale · doi:10.1007/978-3-662-64467-6_2
Neurocognitive Dysfunction in Children and Adolescents with Mental IllnessPreprint
Nesamoney, S., Hilton, R. A., Tozzi, L., & Williams, L. M. (2023) · medRxiv · doi:10.1101/2023.02.23.23286376
Cognitive-Behavioral Therapy for Schizophrenia and Related Psychoses
Nagendra, A., Wright, A. C., Browne, J., Marcus, P. H., & Cather, C. (2023) · Current clinical psychiatry · doi:10.1007/978-3-031-29368-9_19
Metzner, C., Dimulescu, C., Kamp, F., Fromm, S. P., Uhlhaas, P. J., & Obermayer, K. (2023) · medRxiv · doi:10.1101/2023.12.08.23299714
Shimada, Y., Oda, Y., Shibata, S., Hirose, Y., & Sasaki, T. G. (2024) · Cureus · doi:10.7759/cureus.53182
“On the first, second, fifth, and twenty-second days after admission, the patient's Young Mania Rating Scale (YMRS) [12] and Positive and Negative Syndrome Scale (PANSS) [13] scores were 50, 20, 18, and 15 points, and 120, 50, 40, and 35 points, respectively.”
MethodFeria‐Raposo, I., García‐León, M. Á., Rodríguez‐Cano, E., Blanco‐Blanco, J., Moreno‐Casbas, T., Gonzalez‐Castro, A. I., Gómez‐Lozano, M. J., Guerrero‐Pedraza, A., Sarri, C., Portillo, F., et al. (2024) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.13046
Luo, X., Liu, F., Lu, J., Cheng, Y.-Q., Xu, X.-F., He, X.-L., Xia, Y.-B., Gao, C.-Q., Xie, X., Zhao, Y., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05874-1 · Cited by 1
“(2) Positive and Negative Syndrome Scale (PANSS) [12]: It consists of three subscales, including positive symptoms (such as excitement and hostility, hallucinations and delusions, conceptual disorganization and other 7 items), negative symptoms (such as emotional blunting, passive withdrawal,…”
MethodInside the Hospitalization Voyage of Schizophrenia Care: A Single-Center Journey
Pop, R., Crișan, C. A., Micluția, I., Pop, E., Iancu, M., & Bolboaca, S. D. (2024) · Medicina · doi:10.3390/medicina60081214
Wu, G., Zhu, T., Ma, C., Xu, L., Qian, Z., Kong, G., Cui, H., Zhang, T., Wang, J., & Tang, Y. (2024) · Clinical Neurophysiology · doi:10.1016/j.clinph.2024.11.015
Manasa, S. S. V. L., Reddy, E. A., Harshitha, V., Prasanna, V. P., Lekha, C. K., & Krishna, J. S. (2024) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_33_24
Methods to address functional unblinding of raters in CNS trials
Targum, S. D., Horan, W. P., Davis, V. G., Breier, A. F., & Brannan, S. K. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03262-1 · Cited by 1
“…between 80 and 120 (inclusive), a score of at least 4 on at least two of four key positive symptom items (delusions, conceptual disorganization, hallucinatory behavior, suspiciousness), and a Clinical Global Impression of Severity score of at least 4 at the screening and baseline visits [35, 36].”
Foucher, J., Schorr, B., de Billy, C. D. C., Dormegny-Jeanjean, L. C., Mainberger, O., Humbert, I., Clauss, J. M. E., Elowe, J., Weibel, S., Mengin, A. C., et al. (2025) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2023.03.017
Gainsford, K., Fitzgibbon, B. M., Hill, A. T., Fitzgerald, P. B., Gurvich, C., & Hoy, K. E. (2025) · medRxiv · doi:10.1101/2025.05.09.25327343
Hu, Z., Chen, J., Yang, J., Xie, H., Liu, J., Zhang, P., Wu, Q., Doosti, M.-H., Rong, C., Wang, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.29.679140
“The interrater reliability of the PANSS, as per the ratings of the trained interviewers, ranged from 0.76 to 0.92.”
InfluentialAyesa‐Arriola, R., Martínez-Asensi, C., Díaz‐Pons, A., de la Foz, V. O., Parás, C., Mouslih, C. E., Sattari, R., Incera, S., & Palaniyappan, L. K. (2025) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2025.100398
“SSD patients were assessed using the Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1987; Kay et al., 1989; Kay et al., 1988).”
Barber, S., McPhail, L., Xue, S., Greenley, R., Cai, J., Assefa, E., Fekadu, W., Mihretu, A., Weir, H., Keynejad, R. C., et al. (2025) · medRxiv · doi:10.1101/2025.10.20.25338375
Alenius, M. (2009) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Residual and Negative Symptoms in Treatment with Neuroleptics
Kane, J. M. (1993) · Springer eBooks · doi:10.1007/978-3-642-78010-3_13
Shamsalinia, A., Moradi, M., Rad, R. E., Ghadimi, R., Farahani, M. A., Masoudi, R., Rabiei, L., & Ghaffari, F. (2021) · Figshare · doi:10.6084/m9.figshare.14234899
Thibaudeau, É., Giguère-Rancourt, A., Lecomte, T., Corbière, M., Abdel‐Baki, A., Cayouette, A., Marc-André, R., Achim, A. M., Lepage, M., Wykes, T., et al. (2025) · Canadian Journal of Community Mental Health · doi:10.7870/cjcmh-2025-015
Han, Y., Du, Y., Xia, Y. X., Hua, L., Yao, Z., & Lü, Q. (2026) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn-25-0109
Pop, R., Iancu, M., Micluția, I., Crișan, C. A., Pop, E., & Bolboaca, S. D. (2026) · BJPsych Open · doi:10.1192/bjo.2025.10973
Perceptual organization and its relationship to functioning in patients with chronic schizophrenia
Kim, S. K., Lee, J., & Joo, S. W. (2026) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2026.100437
“The severity of psychiatric symptoms was measured using the Positive and Negative Syndrome Scale (PANSS; Kay et al., 1989) and the Clinical Global Impression (CGI; Guy, 1976).”
Antipsychotic Efficacy and Safety of LB-102 in the Treatment of Adults With Acute Schizophrenia
Eramo, A., Correll, C. U., Walling, D. P., Kakar, R., Bassani, N., Callahan, L., Lee, B. P., Prensky, Z., Vaino, A. R., & Kane, J. M. (2026) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2026.0428
Efficacy and safety of Nrf2 activators for schizophrenia: a systematic review and meta-analysis
Okazaki, M., Sakuma, K., Jo, H., Nagata, Y., Hamanaka, S., Nishii, Y., Kitajima, T., Iwata, N., & Kishi, T. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02264-4
“The primary efficacy outcome was over - all symptom improvement based on the total Positive and Negative Syndrome Scale (PANSS) [27] scores and the Brief Psychiatric Rating Scale [38 ] scores.”
Metadata
- Authors
- Kay, S. R., Opler, L. A., & Lindenmayer, J.-P.
- Affiliations
- Albert Einstein College of Medicine (US)
- NewYork–Presbyterian Hospital (US)
- Corresponding author
- Kay, Stanley R.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1989-11
- Volume
- 155
- Issue
- S7
- Pages
- 59-65
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W1688754235
- Cited by
- 1,016
- References
- 36
- Citations by year
- 2026: 22 · 2025: 21 · 2024: 28 · 2023: 30 · 2022: 24 · 2021: 36 · 2020: 30 · 2019: 33 · 2018: 39 · 2017: 53 · 2016: 38 · 2015: 43 · 2014: 37 · 2013: 53 · 2012: 48
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The British Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
- Keywords
- PANSS, schizophrenia, positive symptoms, negative symptoms, symptom classification, psychometric properties, delusions, hallucinations
- MeSH terms
- Chronic Disease, Follow-Up Studies, Humans, Pimozide, Psychiatric Status Rating Scales, Psychometrics, Schizophrenia, Schizophrenic Psychology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review